Research advances in the role of interferon regulatory factor 4(IRF4) in chronic inflammatory diseases

doi:10.16352/j.issn.1001-6325.2022.07.1119

Basic & Clinical Medicine ›› 2022, Vol. 42 ›› Issue (7): 1119-1123.doi: 10.16352/j.issn.1001-6325.2022.07.1119

• Mini Reviews • Previous Articles Next Articles

Research advances in the role of interferon regulatory factor 4(IRF4) in chronic inflammatory diseases

LUAN Ge^1,2, WANG Ming^1,2, WANG Cheng-shuo^1,2*, ZHANG Luo^{1,2, 3*}

1. Department of Otolaryngology Head and Neck Surgery, Key Laboratory of Otolaryngology Head and Neck Surgery of Ministry of Education; 3. Department of Allergology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730;
2. Beijing Institute of Otolaryngology, Beijing Key Laboratory of Nasal Diseases, Beijing 100005, China

Received:2021-01-26 Revised:2021-07-12 Online:2022-07-05 Published:2022-06-29
Contact: * dr.luozhang@139.com;wangcs830@126.com

Abstract

Abstract: Interferon regulatory factor 4 (IRF4) is expressed in a variety of immune cells and participates in the regulation of a variety of immune responses. IRF4 is related to a variety of chronic inflammatory diseases and respiratory allergic diseases. Inhibiting the expression or the function of IRF4 can reduce or delay the occurrence and development of the disease. Studying the role and mechanism of IRF4 in chronic rhinopathy and airway allergic diseases will help provide new strategies for disease treatment.

Key words: interferon regulatory factor 4, chronic inflammatory disease, respiratory allergic disease, immune regulation

CLC Number:

R392

LUAN Ge, WANG Ming, WANG Cheng-shuo, ZHANG Luo. Research advances in the role of interferon regulatory factor 4(IRF4) in chronic inflammatory diseases[J]. Basic & Clinical Medicine, 2022, 42(7): 1119-1123.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.07.1119

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I7/1119

References 25

[1]	Ahyi AN, Chang HC, Dent AL, et al. IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines[J]. J Immunol, 2009, 183: 1598-1606.
[2]	Fu Y, Koh B, Kuwahara M, et al. BATF-Interacting proteins dictate specificity in Th subset activity[J]. J Immunol, 2019, 203: 1989-1998.
[3]	Kang CH, Hartmann E, Menke L, et al. A hyperactive mutant of interferon-regulatory factor 4[J]. Eur J Immunol, 2019, 49: 812-815.
[4]	Staudt V, Bothur E, Klein M, et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells[J]. Immunity, 2010, 33: 192-202.
[5]	Abdelaziz MH, Wang H, Cheng J, et al. Th2 cells as an intermediate for the differentiation of naive T cells into Th9 cells, associated with the Smad3/Smad4 and IRF4 pathway[J]. Exp Ther Med, 2020, 19: 1947-1954.
[6]	Cretney E, Xin A, Shi W, et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells[J]. Nat Immunol, 2011, 12: 304-311.
[7]	Alvisi G, Brummelman J, Puccio S, et al. IRF4 instructs effector Treg differentiation and immune suppression in human cancer[J]. J Clin Invest, 2020, 130: 3137-3150.
[8]	Miyakoda M, Honma K, Kimura D, et al. Differential requirements for IRF4 in the clonal expansion and homeostatic proliferation of naive and memory murine CD8(+) T cells[J]. Eur J Immunol, 2018, 48: 1319-1328.
[9]	Harberts A, Schmidt C, Schmid J, et al. Interferon regulatory factor 4 controls effector functions of CD8(+) memory T cells[J]. Proc Natl Acad Sci U S A, 2021, 118. doi: 10.1073/pnas.2014553118.
[10]	Low MSY, Brodie EJ, Fedele PL, et al. IRF4 activity is required in established plasma cells to regulate gene transcription and mitochondrial homeostasis[J]. Cell Rep, 2019, 29: 2634-2645.
[11]	Ramadani F, Bowen H, Gould HJ, et al. Transcriptional analysis of the human IgE-expressing plasma cell differentiation pathway[J]. Front Immunol, 2019, 10: 402. doi: 10.3389/fimmu.2019.00402.
[12]	Khoenkhoen S, Adori M, Pedersen GK, et al. Flow cytometry-based protocols for the analysis of human plasma cell differentiation[J]. Front Immunol, 2020, 11: 571321. doi: 10.3389/fimmu.2020.571321.
[13]	Schlitzer A, McGovern N, Teo P, et al. IRF4 transcrip-tion factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses[J]. Immunity, 2013, 38: 970-983.
[14]	Moon HG, Kim SJ, Jeong JJ, et al. Airway epithelial eell-derived colony stimulating factor-1 promotes allergen sensitization[J]. Immunity, 2018, 49: 275-287.
[15]	Buchele V, Konein P, Vogler T, et al. Th17 cell-mediated colitis is positively regulated by interferon regulatory factor 4 in a T cell-extrinsic manner[J]. Front Immunol, 2020, 11: 590893. doi: 10.3389/fimmu.2020.590893.
[16]	Pool L, Rivollier A, Agace WW. Deletion of IRF4 in dendritic cells leads to delayed onset of T cell-dependent colitis[J]. J Immunol, 2020, 204: 1047-1055.
[17]	Lee MC, Saleh R, Achuthan A, et al. CCL17 blockade as a therapy for osteoarthritis pain and disease[J]. Arthritis Res Ther, 2018, 20: 62. doi: 10.1186/s13075-018-1560-9.
[18]	Cook AD, Lee MC, Saleh R, et al. TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17[J]. JCI Insight, 2018, 3. doi: 10.1172/jci.insight.99249.
[19]	Han W, Chen X, Wang X, et al. TLR-4, TLR-5 and IRF4 are diagnostic markers of knee osteoarthritis in the middle-aged and elderly patients and related to disease activity and inflammatory factors[J]. Exp Ther Med, 2020, 20: 1291-1298.
[20]	Ansari MA, Nadeem A, Bakheet SA, et al. Chemokine receptor 5 antagonism causes reduction in joint inflammation in a collagen-induced arthritis mouse model[J]. Molecules, 2021, 26. doi: 10.3390/molecules26071839.
[21]	Gu ZW, Wang YX, Cao ZW. Neutralization of interleukin-9 ameliorates symptoms of allergic rhinitis by reducing Th2, Th9, and Th17 responses and increasing the Treg response in a murine model[J]. Oncotarget, 2017, 8: 14314-14324.
[22]	Wu J, Ge D, Zhong T, et al. IRF4 and STAT3 activities are associated with the imbalanced differentiation of T-cells in responses to inhalable particulate matters[J]. Respir Res, 2020, 21: 123. doi: 10.1186/s12931-020-01368-2.
[23]	Zhang X, Artola-Boran M, Fallegger A, et al. IRF4 expression is required for the immunoregulatory activity of conventional type 2 dendritic cells in settings of chronic bacterial infection and cancer[J]. J Immunol, 2020, 205: 1933-1943.
[24]	Buttrick TS, Wang W, Yung C, et al. Foxo1 promotes Th9 cell differentiation and airway allergy[J]. Sci Rep, 2018, 8: 818. doi: 10.1038/s41598-018-19315-z.
[25]	Liu Y, Gao X, Miao Y, et al. NLRP3 regulates macrophage M2 polarization through up-regulation of IL-4 in asthma[J]. Biochem J, 2018, 475: 1995-2008.

Research advances in the role of interferon regulatory factor 4(IRF4) in chronic inflammatory diseases

PDF

Knowledge

Abstract

Cite this article

share this article

References 25

Related Articles 4

Recommended Articles

Metrics

Comments

[1]	. CD11 c+DCs promote the occurrence and development of psoriasis-like morbidity on K14-VEGF transgenic mice [J]. Basic & Clinical Medicine, 2018, 38(2): 205-212.
[2]	. Progress of CD26 in T cell and related immune diseases [J]. Basic & Clinical Medicine, 2018, 38(11): 1635-1639.
[3]	. Isolating culture of adipose mesenchymal stem cells in psoriasis vulgaris patients and the differentiation into immune regulation function [J]. Basic & Clinical Medicine, 2017, 37(7): 975-981.
[4]	Li SONG; Jia-lin CHEN. Immunoregulatory effects of mesenchyma stem cell and its significance in autoimmune disease [J]. Basic & Clinical Medicine, 2009, 29(11): 1221-1223.